Biotech Values

[jbog]

Viking Therapeutics announces $350M common stock offering

Viking Therapeutics announced that it has commenced an underwritten public offering of $350M of shares of its common stock. All of the shares of common stock to be sold in the proposed offering are to be sold by Viking. Viking currently intends to use the net proceeds from the proposed offering for continued development of its VK2809, VK2735 and VK0214 programs and for general research and development, working capital and general corporate purposes. Morgan Stanley, Leerink Partners, William Blair, Raymond James, Stifel and Truist Securities are acting as joint book-running managers for the proposed offering.

Read more at:
https://thefly.com/n.php?id=3871625